BrightSpec
Charlottesville, Virginia, United States · Information Technology, research · 9 employees
BrightSpec is the leading life science tools company commercializing instruments that harness the power of molecular rotational resonance (MRR) spectroscopy. MRR is an innovative approach to rapidly and definitively characterize the unique three-dimensional structure of small molecules, including all forms of structural and spatial isomers. BrightSpec is developing a vertically integrated platform
Funding history
- Series seed — $3.9M — May 2025
- Funding Round — $7.5M — Dec 2022
- Funding Round — $18.4M — Dec 2022
- Series seed — $825K — Oct 2021
- Funding Round — $2.8M — Mar 2019
Recent signals
- Oct 06, 2025: BrightSpec Appoints Rick Gordon as Chief Executive Officer
- May 07, 2025: Raised $3.9M in Series seed
- Mar 03, 2025: Launched BrightSpec launches the BrightSpec-MRR product suite at PittCon 2025, aimed at transforming molecular analysis for businesses.
- Jul 11, 2024: BrightSpec Appoints Damien Fischer as Global VP of Sales and Service and Tim Germann as Independent Director
- Dec 19, 2022: Raised $7.5M
- Dec 14, 2022: Raised $18.4M
- Oct 28, 2021: Raised $825K in Series seed
- Mar 13, 2019: Raised $2.8M
See plans & pricing → Track BrightSpec’s funding, hiring, and signals — with verified contacts — on Fundz.